Eli Lilly & Co. (LLY)
1273.46
-33.23
(-2.54%)
USD |
NYSE |
Oct 23, 16:00
1277.30
+3.84
(+0.30%)
After-Hours: 20:00
Eli Lilly Price to Book Value : 35.39 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 35.39 |
| October 22, 2026 | 36.31 |
| October 21, 2026 | 35.31 |
| October 20, 2026 | 35.67 |
| October 19, 2026 | 34.47 |
| October 16, 2026 | 34.93 |
| October 15, 2026 | 34.78 |
| October 14, 2026 | 33.59 |
| October 13, 2026 | 32.42 |
| October 12, 2026 | 32.87 |
| October 09, 2026 | 32.77 |
| October 08, 2026 | 32.50 |
| October 07, 2026 | 33.03 |
| October 06, 2026 | 32.17 |
| October 05, 2026 | 31.77 |
| October 02, 2026 | 31.76 |
| October 01, 2026 | 31.95 |
| September 30, 2026 | 32.16 |
| September 29, 2026 | 32.92 |
| September 28, 2026 | 32.93 |
| September 25, 2026 | 32.89 |
| September 24, 2026 | 32.84 |
| September 23, 2026 | 31.99 |
| September 22, 2026 | 32.52 |
| September 21, 2026 | 32.37 |
| Date | Value |
|---|---|
| September 18, 2026 | 32.04 |
| September 17, 2026 | 32.03 |
| September 16, 2026 | 31.62 |
| September 15, 2026 | 31.57 |
| September 14, 2026 | 31.63 |
| September 11, 2026 | 31.01 |
| September 10, 2026 | 31.21 |
| September 09, 2026 | 31.24 |
| September 08, 2026 | 31.23 |
| September 04, 2026 | 31.94 |
| September 03, 2026 | 32.23 |
| September 02, 2026 | 32.24 |
| September 01, 2026 | 32.24 |
| August 31, 2026 | 32.15 |
| August 28, 2026 | 32.64 |
| August 27, 2026 | 32.68 |
| August 26, 2026 | 33.05 |
| August 25, 2026 | 34.28 |
| August 24, 2026 | 34.65 |
| August 21, 2026 | 34.89 |
| August 20, 2026 | 34.58 |
| August 19, 2026 | 35.58 |
| August 18, 2026 | 34.06 |
| August 17, 2026 | 32.88 |
| August 14, 2026 | 32.80 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.789 |
| Merck & Co., Inc. | 8.552 |
| Pfizer Inc. | 2.009 |
| Bristol Myers Squibb Co. | 5.628 |
| Structure Therapeutics, Inc. | 1.114 |
Price to Book Value Related Metrics
| PE Ratio | 43.27 |
| PS Ratio | 14.52 |
| PEG Ratio | 0.4548 |
| Price to Free Cash Flow | 85.30 |
| Price | 1273.46 |
| Earnings Yield | 2.31% |
| Market Cap | 1.199T |
| PEGY Ratio | 0.4524 |
| Operating PE Ratio | 29.20 |
| Normalized PE Ratio | 37.34 |